Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activation.

Wullaert A, Verstrepen L, Van Huffel S, Adib-Conquy M, Cornelis S, Kreike M, Haegman M, El Bakkouri K, Sanders M, Verhelst K, Carpentier I, Cavaillon JM, Heyninck K, Beyaert R.

J Biol Chem. 2007 Jan 5;282(1):81-90. Epub 2006 Nov 6.

2.

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.

Verstrepen L, Carpentier I, Verhelst K, Beyaert R.

Biochem Pharmacol. 2009 Jul 15;78(2):105-14. doi: 10.1016/j.bcp.2009.02.009. Epub 2009 Feb 27. Review.

PMID:
19464428
3.

FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling.

Mashima R, Saeki K, Aki D, Minoda Y, Takaki H, Sanada T, Kobayashi T, Aburatani H, Yamanashi Y, Yoshimura A.

J Biol Chem. 2005 Dec 16;280(50):41289-97. Epub 2005 Oct 12.

4.

Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M.

J Biol Chem. 1999 Mar 19;274(12):7611-4.

5.

The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).

Verstrepen L, Carpentier I, Beyaert R.

Adv Exp Med Biol. 2014;809:13-31. Review.

PMID:
25302363
6.

Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.

Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, Beyaert R.

J Cell Mol Med. 2008 Jan-Feb;12(1):316-29. Epub 2007 Dec 10.

7.

Overexpression of ABIN-2, a negative regulator of NF-kappaB, delays liver regeneration in the ABIN-2 transgenic mice.

Li CC, Chou CK, Wang MH, Tsai TF.

Biochem Biophys Res Commun. 2006 Mar 31;342(1):300-9. Epub 2006 Feb 2.

PMID:
16480954
8.

TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.

Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T.

J Biol Chem. 2003 Dec 12;278(50):49751-62. Epub 2003 Sep 30.

9.

Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.

Ando K, Hasegawa K, Shindo K, Furusawa T, Fujino T, Kikugawa K, Nakano H, Takeuchi O, Akira S, Akiyama T, Gohda J, Inoue J, Hayakawa M.

FEBS J. 2010 May;277(9):2051-66. doi: 10.1111/j.1742-4658.2010.07620.x. Epub 2010 Mar 19.

10.

Acrolein with an alpha, beta-unsaturated carbonyl group inhibits LPS-induced homodimerization of toll-like receptor 4.

Lee JS, Lee JY, Lee MY, Hwang DH, Youn HS.

Mol Cells. 2008 Apr 30;25(2):253-7. Epub 2008 Mar 31.

12.

Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.

Van Huffel S, Delaei F, Heyninck K, De Valck D, Beyaert R.

J Biol Chem. 2001 Aug 10;276(32):30216-23. Epub 2001 Jun 4.

13.

Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins.

Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, Löhr F, Wu CJ, Ashwell JD, Dötsch V, Dikic I, Beyaert R.

Oncogene. 2008 Jun 12;27(26):3739-45. doi: 10.1038/sj.onc.1211042. Epub 2008 Jan 21.

PMID:
18212736
14.
15.

The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2.

Hughes DP, Marron MB, Brindle NP.

Circ Res. 2003 Apr 4;92(6):630-6. Epub 2003 Feb 27.

16.

Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.

Chen F, Du Y, Zhang Z, Chen G, Zhang M, Shu HB, Zhai Z, Chen D.

Cell Signal. 2008 Apr;20(4):666-74. doi: 10.1016/j.cellsig.2007.12.002. Epub 2007 Dec 8.

PMID:
18234474
17.

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA.

Hepatology. 2003 May;37(5):1043-55.

PMID:
12717385
18.

Inhibition of homodimerization of Toll-like receptor 4 by curcumin.

Youn HS, Saitoh SI, Miyake K, Hwang DH.

Biochem Pharmacol. 2006 Jun 28;72(1):62-9. Epub 2006 Apr 1.

PMID:
16678799

Supplemental Content

Support Center